Non-Hodgkin Lymphoma | Specialty

The OncLive Non-Hodgkin Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on various types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in non-Hodgkin lymphoma.

Sequencing Monoclonal Antibodies in Myeloma

July 27th 2016

Moving Beyond Medians

July 27th 2016

Novel Agents with Len-Dex in Multiple Myeloma

July 27th 2016

Goals of Therapy for Relapsed Myeloma

July 27th 2016

Treatment Goals Based on Relapse Type in Myeloma

July 27th 2016

All Myeloma Relapses Are Not the Same

July 27th 2016

Efficacy and Safety of Monoclonal Antibodies for Multiple Myeloma

July 27th 2016

Monoclonal Antibodies for Multiple Myeloma

July 27th 2016

Immunotherapy Rationale in Multiple Myeloma

July 27th 2016

Where Immuno-Oncology Is Heading

July 20th 2016

Brentuximab Vedotin in Advanced Lymphoid Malignancies

July 20th 2016

Anti-CD20 Antibodies for Advanced Hematologic Malignancies

July 20th 2016

Obinutuzumab for Indolent Lymphoma

July 20th 2016

Immunochemotherapy for Lymphoma

July 20th 2016

Resistance with CAR-T Therapy

July 20th 2016

Where Does CAR-T Fit in the Context of Transplant?

July 20th 2016

Recent Trials of CAR-T Therapy

July 20th 2016

Toxicity Management for CAR-T in Hematologic Malignancies

July 20th 2016

Obstacles to Using CAR-T Therapy in Hematologic Malignancies

July 20th 2016

CAR-T Cell Therapy in Hematologic Malignancies

July 20th 2016